TELA Bio, Inc. - Common Stock, par value $0.001 per share (TELA) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2019 to Q3 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Symbol
TELA on Nasdaq
Shares outstanding
44,542,200
Price per share
$1.17
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
23,562,953
Total reported value
$35,108,965
% of total 13F portfolios
0%
Share change
+87,526
Value change
+$70,985
Number of holders
40
Price from insider filings
$1.17
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of TELA Bio, Inc. - Common Stock, par value $0.001 per share (TELA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
EW HEALTHCARE PARTNERS FUND 2, L.P. 17% $11,572,064 7,714,709 EW Healthcare Partners Fund 2 GP, L.P. 17 Nov 2025
Nantahala Capital Management, LLC 13% +29% $5,264,936 +$1,171,380 5,111,588 +29% Nantahala Capital Management, LLC 30 Apr 2025
NORTH RUN CAPITAL, LP 9.3% $3,608,839 3,682,489 North Run Capital, LP 31 Mar 2025
SILVERARC CAPITAL MANAGEMENT, LLC 7.8% $3,157,618 3,065,649 SilverArc Capital Management, LLC 31 Dec 2024
LYTTON LAURENCE W 7.2% -14% $4,269,304 -$832,740 2,865,305 -16% Lytton, Laurence W. 30 Sep 2025
Stonepine Capital Management, LLC 6% $2,423,692 2,353,099 Stonepine Capital Management, LLC 31 Dec 2024
HIRSCHMAN ORIN 3.6% -46% $1,458,813 -$1,283,856 1,416,323 -47% Orin Hirschman 31 Mar 2025

As of 30 Sep 2025, 40 institutional investors reported holding 23,562,953 shares of TELA Bio, Inc. - Common Stock, par value $0.001 per share (TELA). This represents 53% of the company’s total 44,542,200 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of TELA Bio, Inc. - Common Stock, par value $0.001 per share (TELA) together control 53% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Nantahala Capital Management, LLC 11% 5,111,588 0% 0.47% $7,616,266
Essex Woodlands Management, Inc. 9.2% 4,110,709 0% 2% $6,124,956
SILVERARC CAPITAL MANAGEMENT, LLC 6.2% 2,782,923 +0.11% 0.6% $4,146,555
Stonepine Capital Management, LLC 4.8% 2,155,519 +3.4% 2.6% $3,211,723
VANGUARD GROUP INC 4% 1,799,884 -5.8% 0% $2,681,827
DAFNA Capital Management LLC 3.2% 1,441,029 0% 0.53% $2,147,133
PERKINS CAPITAL MANAGEMENT INC 1.9% 833,928 -4.8% 1.1% $1,242,553
CITIGROUP INC 1.7% 750,000 0% 0% $1,117,500
Velan Capital Investment Management LP 1.7% 747,410 0% 1% $1,113,641
Pentwater Capital Management LP 1.6% 724,856 -11% 0.01% $1,080,035
Sio Capital Management, LLC 1.4% 636,300 0% 0.24% $948,087
BlackRock, Inc. 1% 460,606 +0.46% 0% $686,304
GEODE CAPITAL MANAGEMENT, LLC 0.8% 356,721 +5.6% 0% $531,581
WealthTrust Axiom LLC 0.52% 231,938 +1031% 0.09% $345,587
UBS Group AG 0.49% 216,802 -12% 0% $323,035
PARADIGM CAPITAL MANAGEMENT INC/NY 0.45% 200,000 0% 0.01% $298,000
NORTHERN TRUST CORP 0.39% 175,319 +86% 0% $261,225
Birchview Capital, LP 0.35% 155,000 0% 0.17% $230,950
GSA CAPITAL PARTNERS LLP 0.24% 105,809 +107% 0.01% $158,000
UP STRATEGIC WEALTH INVESTMENT ADVISORS LLC 0.22% 99,888 0% 0.11% $147,834
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.19% 85,763 +551% 0% $127,787
RENAISSANCE TECHNOLOGIES LLC 0.14% 63,900 -5.1% 0% $95,211
STATE STREET CORP 0.14% 63,383 0% 0% $94,441
BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.13% 57,500 0% 0% $85,675
PNC Financial Services Group, Inc. 0.12% 53,612 0% 0% $79,882

Institutional Holders of TELA Bio, Inc. - Common Stock, par value $0.001 per share (TELA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 23,562,953 $35,108,965 +$70,985 $1.49 40
2025 Q2 23,475,441 $45,542,765 -$775,817 $1.94 45
2025 Q1 24,589,431 $30,000,578 -$5,393,767 $1.22 47
2024 Q4 27,032,996 $81,640,185 +$27,788,574 $3.02 46
2024 Q3 18,012,190 $45,588,967 -$10,957,151 $2.53 48
2024 Q2 19,879,104 $93,431,204 -$6,727,769 $4.70 67
2024 Q1 20,686,484 $117,291,525 -$1,440,674 $5.67 58
2023 Q4 20,961,753 $138,768,000 -$8,556,712 $6.62 59
2023 Q3 21,852,278 $174,817,192 -$1,837,652 $8.00 66
2023 Q2 22,055,151 $223,420,525 +$51,494,147 $10.13 67
2023 Q1 16,939,491 $180,199,912 -$5,749,427 $10.64 54
2022 Q4 17,430,212 $200,446,271 +$6,246,136 $11.50 49
2022 Q3 16,786,563 $143,023,324 +$28,855,193 $8.52 43
2022 Q2 13,534,368 $95,028,004 +$21,079,273 $7.01 31
2022 Q1 0 $0 -$6,159,015 $1.17 0
2021 Q4 10,531,506 $134,807,000 -$160,975 $12.80 34
2021 Q3 10,239,133 $139,839,000 -$331,937 $13.66 36
2021 Q2 10,239,199 $164,949,850 +$6,144,103 $16.11 44
2021 Q1 9,891,266 $147,387,000 +$2,988,780 $14.90 46
2020 Q4 9,690,658 $145,766,000 -$988,973 $15.04 47
2020 Q3 9,752,756 $161,293,000 +$2,115,721 $16.54 43
2020 Q2 9,735,757 $126,197,000 +$40,257,091 $12.96 49
2020 Q1 6,476,845 $50,649,000 -$2,643,981 $7.82 26
2019 Q4 6,384,233 $82,677,000 +$79,084,018 $12.95 22